Published in Adv Drug Deliv Rev on April 14, 2010
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med (2012) 1.19
Cell- and gene-based therapeutic strategies for periodontal regenerative medicine. J Periodontol (2011) 1.04
Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther (2012) 0.99
Barriers to the clinical translation of orthopedic tissue engineering. Tissue Eng Part B Rev (2011) 0.98
Bone repair cells for craniofacial regeneration. Adv Drug Deliv Rev (2012) 0.97
Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature. Open Orthop J (2011) 0.97
Regenerative medicine in 2012: the coming of age of musculoskeletal tissue engineering. Nat Rev Rheumatol (2013) 0.95
Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad: the effects of free fatty acids. Int J Obes (Lond) (2012) 0.91
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery. Tissue Eng Part B Rev (2013) 0.90
Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential. Stem Cell Res Ther (2014) 0.89
An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev (2014) 0.83
TGF-β1 conjugated chitosan collagen hydrogels induce chondrogenic differentiation of human synovium-derived stem cells. J Biol Eng (2015) 0.81
Current status of bone graft options for anterior interbody fusion of the cervical and lumbar spine. Neurosurg Rev (2013) 0.80
Identification of stable reference genes for gene expression analysis of three-dimensional cultivated human bone marrow-derived mesenchymal stromal cells for bone tissue engineering. Tissue Eng Part C Methods (2014) 0.80
Mechanical characterization of adult stem cells from bone marrow and perivascular niches. J Biomech (2012) 0.79
Functional cartilage repair capacity of de-differentiated, chondrocyte- and mesenchymal stem cell-laden hydrogels in vitro. Osteoarthritis Cartilage (2014) 0.78
Mesenchymal stem cells derived from vertebrae (vMSCs) show best biological properties. Eur Spine J (2013) 0.76
Thiol-ene click hydrogels for therapeutic delivery. ACS Biomater Sci Eng (2016) 0.75
Autologous Cell Delivery to the Skin-Implant Interface via the Lumen of Percutaneous Devices in vitro. J Funct Biomater (2010) 0.75
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer. Front Pharmacol (2017) 0.75
Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res (2002) 4.71
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97
Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells (2007) 3.79
Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71
Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am (2011) 2.37
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J (2004) 2.30
Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25
Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res (2002) 2.18
Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials (2005) 2.18
Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater (2006) 2.14
Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A (2003) 2.07
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06
Transient exposure to transforming growth factor beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage. Tissue Eng Part A (2008) 1.95
Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol (2002) 1.90
Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells (2014) 1.89
Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng Part B Rev (2009) 1.88
Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage (2004) 1.87
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum (2008) 1.83
Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells (2003) 1.82
MicroRNAs and cell differentiation in mammalian development. Birth Defects Res C Embryo Today (2006) 1.78
Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 1.78
Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther (2008) 1.75
iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev (2010) 1.73
Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol (2010) 1.68
Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol (2008) 1.67
Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol (2006) 1.66
Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A (2008) 1.63
Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol (2006) 1.59
Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng (2006) 1.54
Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem (2007) 1.52
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther (2012) 1.48
Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem (2009) 1.47
Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol (2007) 1.46
Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner. Tissue Eng Part A (2009) 1.43
How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Deliv Rev (2012) 1.38
Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng (2004) 1.34
Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential. Regen Med (2010) 1.32
Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Anat Rec (Hoboken) (2007) 1.30
Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem (2004) 1.30
Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am (2008) 1.28
Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials (2012) 1.28
Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem (2007) 1.27
Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dyn (2002) 1.27
Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells (2006) 1.26
Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem (2002) 1.25
Detection of periprosthetic infections with use of ribosomal RNA-based polymerase chain reaction. J Bone Joint Surg Am (2010) 1.23
Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev (2010) 1.22
Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol (2008) 1.22
Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res (2009) 1.22
Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs (2010) 1.21
Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A (2008) 1.20
Effects of TGF-beta1 and triiodothyronine on cartilage maturation: in vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res (2006) 1.20
Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res (2009) 1.20
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med (2012) 1.19
Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med (2011) 1.19
Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials (2012) 1.18
Current state of cartilage tissue engineering. Arthritis Res Ther (2003) 1.17
Intervertebral disc cell response to dynamic compression is age and frequency dependent. J Orthop Res (2009) 1.16
Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther (2010) 1.16
In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng (2005) 1.14
Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol (2010) 1.14
Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol (2011) 1.14
Reduced postoperative pain in total hip arthroplasty after minimal-invasive anterior approach. Int Orthop (2011) 1.13
Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today (2009) 1.13
Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine (Phila Pa 1976) (2002) 1.12
Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study. J Tissue Eng Regen Med (2009) 1.10
Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res (2003) 1.10
Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty (2004) 1.08
Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem (2009) 1.08
Concepts in gene therapy for cartilage repair. Injury (2008) 1.08
Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem (2002) 1.08
A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol (2003) 1.07
In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng (2002) 1.07
Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis Rheum (2006) 1.07
Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res (2002) 1.07
BMP12 and BMP13 gene transfer induce ligamentogenic differentiation in mesenchymal progenitor and anterior cruciate ligament cells. Cytotherapy (2010) 1.06
Adult mesenchymal stem cells: biological properties, characteristics, and applications in maxillofacial surgery. J Oral Maxillofac Surg (2007) 1.06
TGF-beta1 calcium signaling in osteoblasts. J Cell Biochem (2007) 1.06
Spatiotemporal protein distribution of TGF-betas, their receptors, and extracellular matrix molecules during embryonic tendon development. Dev Dyn (2008) 1.06
Repair of porcine articular cartilage defect with a biphasic osteochondral composite. J Orthop Res (2007) 1.05
Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. J Cell Biochem (2009) 1.04
Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther (2014) 1.04
Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor. J Surg Res (2008) 1.03
Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag (2003) 1.03
Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol (2005) 1.03
A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum (2009) 1.03
Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. Stem Cells Dev (2004) 1.01
Repair of porcine articular cartilage defect with autologous chondrocyte transplantation. J Orthop Res (2005) 1.01
Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today (2003) 1.01
Enhancement of tenogenic differentiation of human adipose stem cells by tendon-derived extracellular matrix. Biomaterials (2013) 1.01
Application of visible light-based projection stereolithography for live cell-scaffold fabrication with designed architecture. Biomaterials (2012) 1.00
Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther (2010) 1.00
Long-term in vitro analysis of limb cartilage development: involvement of Wnt signaling. J Cell Biochem (2004) 1.00
Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther (2012) 0.99
Cartilage oligomeric matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells. J Cell Biochem (2012) 0.99